CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced that JAMA Oncology, the prestigious peer-reviewed Journal of the American Medical …
Oppenheimer’s healthcare analyst Christopher Marai came out with a research report on CytRx Corporation (NASDAQ:CYTR), reiterating an Outperform rating and a $10 price …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months endedJune 30, 2015, and …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the closing of its previously announced underwritten public offering. The …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the pricing of its previously announced underwritten public offering. CytRx …
Tesla Motors Inc (NASDAQ:TSLA) shares fell nearly -5% in pre-market trading after the company received a downgrade from Colin Langan at UBS. The …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced its intention, subject to market and other conditions, to commence …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, unveiled its proprietary LADR™ (Linker Activated Drug Release) technology platform, a …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the presentation of interim results from its ongoing open-label Phase …
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the appointment of Cheryl Cohen, former Chief Commercial Officer of …
